High Net Worth Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-246
Closed -$31.4K – 597
2022
Q4
$31.4K Hold
246
– – 0.01% 387
2022
Q3
$26K Hold
246
– – 0.01% 420
2022
Q2
$26K Hold
246
– – 0.01% 411
2022
Q1
$31K Sell
246
-7
-3% -$844 0.01% 399
2021
Q4
$31K Buy
+253
New +$33.1K 0.01% 402

Other funds holding ZBH

High Net Worth Advisory Group's ZBH Position: Q1 2023 in Review

High Net Worth Advisory Group sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 246 shares — an estimated $31.4K sold.

High Net Worth Advisory Group first reported a position in ZBH in Q4 2021 and held it in 5 quarters. The position peaked at $31.4K in Q4 2022. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.

  • High Net Worth Advisory Group reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
  • High Net Worth Advisory Group sold 246 Zimmer Biomet shares in Q1 2023, an estimated $31.4K.
  • High Net Worth Advisory Group first reported a position in Zimmer Biomet in Q4 2021 and held it in 5 quarters.
  • High Net Worth Advisory Group's Zimmer Biomet position peaked at $31.4K in Q4 2022.
  • 993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.

Based on High Net Worth Advisory Group's 13F filing for Q1 2023, filed 20 Apr 2023.